Health Care
Commentary
Small-Molecule Price Controls Are Short-Sighted
There’s never been a better time to get lung cancer in the United States. That may sound morbid. But this deadliest of cancers appears to be losing a bit of its punch. The combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over ...
Commentary
Thanks to Biden, US Insurance Market Takes It in the Teeth
When in doubt, mandate. That has long been one of the unspoken principles guiding the left’s approach to health policy. A newly finalized rule from the Biden administration offers a fresh example of this pathology in action. Starting in 2027, the reform gives states the option of adding coverage for adult dental ...
Commentary
Learn about Sen. Sanders' latest scheme to cut drug prices
Why Bernie Sanders’ Ozempic crusade is misguided
Wouldn’t it be nice if we didn’t have to pay for the things we want? That’s the long and short of U.S. Sen. Bernie Sanders’ latest harebrained scheme to cut drug prices. In the Vermont independent’s capacity as chairman of the Senate Health, Education, Labor and Pensions Committee, Sanders sent ...
Commentary
Read the latest on Medicaid reform
Limit Medicaid enrollment to alleviate wait times
The Biden administration is trying to help people on Medicaid see the doctor faster. The Centers for Medicare and Medicaid Services just finalized a regulation establishing a maximum wait of 15 business days for a Medicaid beneficiary to get a primary care appointment. Decreeing that wait times must be shorter ...
Commentary
People think Medicare is going bankrupt
People are pessimistic about Medicare’s longevity. Roughly 7 in 10 adults under 65 say they’re “worried” or “extremely worried” the program won’t be around when they need it, according to a new Gallup poll. That may come as no surprise. Medicare expenditures exceeded $1 trillion in 2023. They’re on track to grow by roughly $930 billion over the next ...
Biosimilars
NEW ISSUE BRIEF: Biosimilar Competition Lowers Patient Drug Costs, New Competition Will Bring Even More Savings
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute provides the latest evidence that biosimilar competition is saving patients billions – and additional competition would increase savings even more. Click to download the brief From 2019-2023, patients saved $15 billion ...
Commentary
Read the latest on drug innovation
How The FDA’s Sunscreen Skepticism Burns Americans
Every day, nearly 10,000 people in the United States are diagnosed with skin cancer. The good news is that applying sunscreen can substantially reduce a person’s risk of getting skin cancer. The bad news is that the federal government is doing its best to keep effective sunscreens out of the hands of ...
Commentary
Read the latest on the Affordable Care Act
Why Next President Needs to Scrap Enhanced Subsidies
The Affordable Care Act’s defenders are sounding the alarm over the health law’s future under a possible second Trump presidency. The conventional wisdom suggests that, should Donald Trump win in November, the enhanced premium subsidies signed into law by President Joe Biden would be allowed to expire on December 31, 2025. That ...
Commentary
Medicaid’s Mission Creep Is Hurting the Poor and Disabled
What do air conditioners, mini fridges, and air purifiers have in common? According to Medicaid authorities in Oregon, they’re all forms of health care. Across the country, state Medicaid programs are suffering from a serious case of mission creep. Officials are trying to use Medicaid dollars to pay for everything ...
Commentary
Read the latest on drug pricing
Insulin Prices Fall, Democrats Respond With Denial
For years, the left’s campaign to dictate the price of prescription drugs has focused on one medicine above all others — insulin. The hormone was discovered more than a century ago by Canadian doctor Frederick Banting and his medical student Charles Best. They famously sold their patent to the University of ...
Small-Molecule Price Controls Are Short-Sighted
There’s never been a better time to get lung cancer in the United States. That may sound morbid. But this deadliest of cancers appears to be losing a bit of its punch. The combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over ...
Thanks to Biden, US Insurance Market Takes It in the Teeth
When in doubt, mandate. That has long been one of the unspoken principles guiding the left’s approach to health policy. A newly finalized rule from the Biden administration offers a fresh example of this pathology in action. Starting in 2027, the reform gives states the option of adding coverage for adult dental ...
Learn about Sen. Sanders' latest scheme to cut drug prices
Why Bernie Sanders’ Ozempic crusade is misguided
Wouldn’t it be nice if we didn’t have to pay for the things we want? That’s the long and short of U.S. Sen. Bernie Sanders’ latest harebrained scheme to cut drug prices. In the Vermont independent’s capacity as chairman of the Senate Health, Education, Labor and Pensions Committee, Sanders sent ...
Read the latest on Medicaid reform
Limit Medicaid enrollment to alleviate wait times
The Biden administration is trying to help people on Medicaid see the doctor faster. The Centers for Medicare and Medicaid Services just finalized a regulation establishing a maximum wait of 15 business days for a Medicaid beneficiary to get a primary care appointment. Decreeing that wait times must be shorter ...
People think Medicare is going bankrupt
People are pessimistic about Medicare’s longevity. Roughly 7 in 10 adults under 65 say they’re “worried” or “extremely worried” the program won’t be around when they need it, according to a new Gallup poll. That may come as no surprise. Medicare expenditures exceeded $1 trillion in 2023. They’re on track to grow by roughly $930 billion over the next ...
NEW ISSUE BRIEF: Biosimilar Competition Lowers Patient Drug Costs, New Competition Will Bring Even More Savings
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute provides the latest evidence that biosimilar competition is saving patients billions – and additional competition would increase savings even more. Click to download the brief From 2019-2023, patients saved $15 billion ...
Read the latest on drug innovation
How The FDA’s Sunscreen Skepticism Burns Americans
Every day, nearly 10,000 people in the United States are diagnosed with skin cancer. The good news is that applying sunscreen can substantially reduce a person’s risk of getting skin cancer. The bad news is that the federal government is doing its best to keep effective sunscreens out of the hands of ...
Read the latest on the Affordable Care Act
Why Next President Needs to Scrap Enhanced Subsidies
The Affordable Care Act’s defenders are sounding the alarm over the health law’s future under a possible second Trump presidency. The conventional wisdom suggests that, should Donald Trump win in November, the enhanced premium subsidies signed into law by President Joe Biden would be allowed to expire on December 31, 2025. That ...
Medicaid’s Mission Creep Is Hurting the Poor and Disabled
What do air conditioners, mini fridges, and air purifiers have in common? According to Medicaid authorities in Oregon, they’re all forms of health care. Across the country, state Medicaid programs are suffering from a serious case of mission creep. Officials are trying to use Medicaid dollars to pay for everything ...
Read the latest on drug pricing
Insulin Prices Fall, Democrats Respond With Denial
For years, the left’s campaign to dictate the price of prescription drugs has focused on one medicine above all others — insulin. The hormone was discovered more than a century ago by Canadian doctor Frederick Banting and his medical student Charles Best. They famously sold their patent to the University of ...
